Evidence map›Paper›PMID 31897289›Full record

ArticleInterface focus2020

A general method for multiscale modelling of vector-borne disease systems.

Winston Garira, Faraimunashe Chirove

Open access · bronzeAbstract read
In one paragraph

Article in Interface focus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Winston GariraDepartment of Mathematics and Applied Mathematics, University of Venda, Thohoyandou, South Africa.ORCID 0000-0001-8909-2236
Faraimunashe ChiroveDepartment of Mathematics and Applied Mathematics, University of Johannesburg, Auckland Park, South Africa.ORCID 0000-0001-6820-688X
University of Johannesburg · ZAUniversity of Venda · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inability to develop multiscale models which can describe vector-borne disease systems in terms of the complete pathogen life cycle which represents multiple targets for control has hindered progress in our efforts to control, eliminate and even eradicate these multi-host infections. This is because it is currently not easy to determine precisely where and how in the life cycles of vector-borne disease systems the key constrains which are regarded as crucial in regulating pathogen population dynamics in both the vertebrate host and vector host operate. In this article, we present a general method for development of multiscale models of vector-borne disease systems which integrate the within-host and between-host scales for the two hosts (a vertebrate host and a vector host) that are implicated in vector-borne disease dynamics. The general multiscale modelling method is an extension of our previous work on multiscale models of infectious disease systems which established a basic science and accompanying theory of how pathogen population dynamics at within-host scale scales up to between-host scale and in turn how it scales down from between-host scale to within-host scale. Further, the general method is applied to multiscale modelling of human onchocerciasis-a vector-borne disease system which is sometimes called river blindness as a case study.

Indexed as

community pathogen loadimmuno-epidemiological modelslinking within-host and between-host scale modelsmultiscale modelling of human onchocerciasismultiscale models of disease systemsmultiscale models of vector-borne diseases

Identifiers

PMID31897289
PMCPMC6936014
OpenAlexW2995905504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.